Potential Savings in the Cost of Caring for Alzheimer’s DiseaseTreatment with Rivastigmine

被引：0
|
作者：
A. Brett Hauber
Josephine A. Mauskopf
Edward H. Snyder
机构：
[1] Parametric Research Corporation Warrington,
[2] RTI Health Solutions,undefined
[3] Research Triangle Institute,undefined
[4] Novartis Pharma A.G.,undefined
[5] East Hanover,undefined
来源：
PharmacoEconomics | 2000年 / 18卷 / 6期
关键词：
Cost Saving; Rivastigmine; Pharmacoeconomic Analysis; Drug Treatment Cost; Average Total Duration;
D O I：
10.2165/00019053-200018060-00008
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：609 / 612
页数：3
相关论文
共 50 条
  • [21] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [22] POTENTIAL COST SAVINGS FOR SELECTED NON-PHARMACOLOGICAL TREATMENT STRATEGIES FOR PATIENTS WITH ALZHEIMER'S DISEASE IN FINLAND
    ROSENVALL, Ari
    SaeaeKSVUORI, Lauri
    FINNE-SOVERI, Harriet
    LINNOSMAA, Ismo
    MALMIVAARA, Antti
    JOURNAL OF REHABILITATION MEDICINE, 2020, 52 (09)
  • [23] Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease
    Ismail, Manal Fouad
    ElMeshad, Aliaa Nabil
    Salem, Neveen Abdel-Hameed
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 393 - 406
  • [24] Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease - A systematic review
    Clegg, A
    Bryant, J
    Nicholson, T
    McIntyre, L
    De Broe, S
    Gerard, K
    Waugh, N
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 497 - 507
  • [25] COST-EFFECTIVENESS ANALYSIS OF DONEPEZIL AND RIVASTIGMINE FOR MILD TO MODERATE ALZHEIMER'S DISEASE IN TAIWAN
    Chen, T. S.
    Lang, H. C.
    VALUE IN HEALTH, 2013, 16 (03) : A104 - A104
  • [26] Rivastigmine in the treatment of Alzheimer's disease: an update
    Onor, Maria Luisa
    Trevisiol, Marianna
    Aguglia, Eugenio
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01): : 17 - 32
  • [27] Alzheimer's disease:: efficacy and tolerance of rivastigmine
    Hébert, M
    PRESSE MEDICALE, 1999, 28 (32): : 1757 - 1758
  • [28] Quetiapine and rivastigmine for agitation in Alzheimer’s disease
    Raymond L. Ownby
    Current Psychiatry Reports, 2006, 8 (1) : 10 - 10
  • [29] The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheimer's disease in Thailand private hospital
    Pattanaprateep, O
    Phongchareonsuk, P
    Chaikledkaew, U
    VALUE IN HEALTH, 2005, 8 (03) : 314 - 315
  • [30] New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease
    Bon, Leo
    Banas, Angelika
    Dias, Ines
    Melo-Marques, Ines
    Cardoso, Sandra M.
    Chaves, Silvia
    Santos, M. Amelia
    PHARMACEUTICS, 2024, 16 (02)
12345